Compare Crescent Energy Company Class A Common Stock (CRGY) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crescent Energy Company Class A Common Stock vs Inovio Pharmaceuticals Inc — how do they compare? Crescent Energy Company Class A Common Stock trades at $12.66 (market cap $4.30B), while Inovio Pharmaceuticals Inc trades at $1.15 (market cap $112.19M). The key difference: Crescent Energy Company Class A Common Stock is far larger — about 38.3× Inovio Pharmaceuticals Inc's market cap, and Crescent Energy Company Class A Common Stock pays a 3.69% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crescent Energy Company Class A Common Stock for 1 Days and Inovio Pharmaceuticals Inc for 43 Days on average.
| CRGY | INO | |
|---|---|---|
Market Cap | $4.30B | $112.19M |
Volume | 15,201,625 | 3,201,278 |
Sector | Energy | Health |
52-Week High | $15.37 | $2.60 |
52-Week Low | $7.75 | $0.66 |
Typical Hold Time | 1 Days | 43 Days |
Enterprise Value | $9.31B | $83.51M |
Dividend Yield | 3.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INO trades at $1.09, down 5.63% today, with a bearish technical outlook and negative financial metrics including a net income margin of -130,000% and ROE of -409.87%. The company faces significant fundamental challenges with minimal revenue of $65,340 and substantial losses, though recent earnings have beaten expectations. Key near-term catalyst is the FDA decision on INO-3107 by October 30, 2026.
Despite analyst consensus favoring Buy ratings (58.83%) with a $2.75 price target, INO carries high risk due to persistent cash burn, negative profitability, and dependency on regulatory approvals. The stock offers speculative upside if INO-3107 gains approval but remains vulnerable to further dilution and operational setbacks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Crescent Energy Company Class A Common Stock
Crescent Energy acquires, develops, and produces oil and natural gas from onshore U.S. basins. Its portfolio includes producing assets with oil and natural gas exposure.
Read more on CRGY →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
